Severe Photo Toxicity Recalled by Docetaxel
Open Access
- 12 November 2018
- journal article
- case report
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 11 (3) , 751-755
Abstract
Photo-recall phenomenon is a rarely recognized adverse event of chemotherapeutic agents. The physiopathology of this entity is unclear. We have reported a 56-year old breast cancer patient with severe photo toxicity recalled 5 months after the initial sunburn by one course of adjuvant docetaxel treatment. However, being given right diagnosis and proper managements the patient could be able to complete her adjuvant chemotherapy according to the planed time schedule, without any delay. Our case may be explained by the theory that long-lived memory T-cells may remember former skin damage and cross-react with cytotoxic drugs. In addition, we have proved that weekly paclitaxel can still be the drug of option after docetaxel recalled severe photo toxicity.Keywords
This publication has 6 references indexed in Scilit:
- Docetaxel‐induced photo‐recall phenomenonPhotodermatology, Photoimmunology & Photomedicine, 2012
- Docetaxel/Cyclophosphamide–Induced Ultraviolet Recall DermatitisJournal of Clinical Oncology, 2011
- Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapyJournal of the American Academy of Dermatology, 2007
- Double Diagnosis in Cancer Patients and Cutaneous Reaction Related to GemcitabineJournal of Clinical Oncology, 2005
- Recall Phenomenon: Some Skin-Resident Cells Remember Previous InsultsDermatology, 2003
- Photo Recall Phenomenon: An Adverse Reaction to TaxanesDermatology, 2003